Biotech Values

[AlpineBV_Miller]

One little known difference for atacicept is it deals with not only BLyS and APRIL, but also a heterotrimer that has been shown to induce B-cell proliferation in vitro. If that heterotrimer indeed has some causality in vivo, then only atacicept has the ability to get at it.